by Parshwa Turakhiya | Oct 12, 2026 | General
Strategy (NASDAQ:MSTR) bought 250 Bitcoin (CRYPTO: BTC) for $21.5 million last week, extending its buying streak even as the stock tests a key resistance level. What the Filing Shows Strategy disclosed in a Monday filing that it purchased the Bitcoin between Oct. 5...
by Erica Kollmann | Oct 12, 2026 | General
Benzinga asked three AI chatbots the same question: which U.S.-listed stock is best positioned to outperform from Monday, Oct. 12, through Friday, Oct. 16? Each model had to search current market data and news, then name one top pick and two runners-up. Two of the...
by Benzinga Insights | Oct 12, 2026 | General
Cerence (NASDAQ:CRNC) released third-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to...
by Benzinga Insights | Oct 12, 2026 | General
PAR Technology (NYSE:PAR) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to...
by Vandana Singh | Oct 12, 2026 | General
On Monday, AstraZeneca Plc (NYSE:AZN) shared detailed results from the HICKORY Phase 3 trial of efzimfotase alfa (ALXN1850) for hypophosphatasia (HPP), an inherited metabolic disease caused by deficient activity of the enzyme alkaline phosphatase (ALP), which helps in...
Recent Comments